Multicenter validation of a reproducible flow cytometric score

Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European Leukemia. NET study by Matteo G. Della Porta, Cristina Picone, Cristiana Pascutto, Luca Malcovati, Hideto Tamura, Hiroshi Handa, Magdalena Czader, Sylvie Freeman, Paresh Vyas, Anna Porwit, Leonie Saft, Theresia M. Westers, Canan Alhan, Claudia Cali, Arjan A. van de Loosdrecht, and Kiyoyuki Ogata haematol Volume 97(8): 1209 -1217 August 1, 2012 © 2012 by Ferrata Storti Foundation

Clinical characteristics of the learning and validation cohort. Matteo G. Della Porta et al. Haematologica 2012; 97: 12091217 © 2012 by Ferrata Storti Foundation

Analysis of four parameters from a sample of cells stained with CD 34 and CD 45 antibodies. Matteo G. Della Porta et al. Haematologica 2012; 97: 12091217 © 2012 by Ferrata Storti Foundation

Values of cytometric variables (expressed as median and ranges) in patients in the learning cohort. Matteo G. Della Porta et al. Haematologica 2012; 97: 12091217 © 2012 by Ferrata Storti Foundation

Calculation of the flow cytometric score (FCM-score) for the diagnosis of low-risk MDS. Matteo G. Della Porta et al. Haematologica 2012; 97: 12091217 © 2012 by Ferrata Storti Foundation

Application of the FCM-score in the learning and validation cohorts. Matteo G. Della Porta et al. Haematologica 2012; 97: 12091217 © 2012 by Ferrata Storti Foundation